AI-Powered Microbiome Intelligence for Human Health

Alphabiome’s groundbreaking technology extracts genetic biomarkers from microbial DNA at an unprecedented scale and precision to predict the efficacy of biological and biochemical treatments.

Science & News

21/11/2025

New peer-reviewed publication: Alphabiome.ai AI Model Proven in Large-Scale Dairy Study

Our AI model, predicting the efficacy of an allicin-based essential oil for methane reduction, was peer-reviewed in Frontiers. The study validated our approach in 339 dairy cows on ten commercial farms.

25/11/2025

Dr. Yaniv Altshuler Presents Alphabiome’s Microbiome-AI Breakthroughs at AIDDD Summit

At the recent AIDDD Summit, our CEO highlighted Alphabiome’s cutting-edge microbiome-AI technology and its growing impact on precision treatment prediction.

25/09/2025

Validation of Alphabiome’s AI model for predicting microbiome-driven outcomes

A peer-reviewed study confirms the accuracy of Alphabiome’s AI model, validated in a controlled livestock trial assessing the methane-reducing effect of a nutritional additive.

06/05/2025

Alphabiome Unveils Revolutionary AI Technology for Microbiome Decoding

Yahoo Finance- Using proprietary algorithms and advanced modeling, Alphabiome deciphers hidden microbial DNA to accurately predict individual drug response — setting a new standard in personalized medicine.

06/05/2025

AI That Predicts Drug Response Powered by the Microbiome

Health Technolog Net- Alphabiome’s proprietary platform analyzes microbial DNA beyond reference genomes, delivering unmatched accuracy in forecasting therapeutic outcomes.

07/05/2025

Alphabiome Raises $8M to Scale Microbiome AI

Finsmes.com- Alphabiome secures seed funding to expand R&D and advance its proprietary platform for predicting drug response with greater precision.

Cracking the Genetic Code of the Microbiome

The microbiome holds immense untapped potential for predicting drug efficacy. Alphabiome’s revolutionary AI platform deciphers the previously inaccessible 99% of microbial genetic data with groundbreaking precision, identifying valuable biomarkers at unprecedented scale and unlocking new possibilities for precision medicine.

Discover Alphabiome

Learn more about how Alphabiome’s groundbreaking technology is opening new frontiers in precision medicine.

About Us

What We Do

Combine advanced AI with reference-free microbiome analytics to uncover genetic biomarkers that predict treatment response.
Apply novel unsupervised AI models to detect hidden patterns across trillions of DNA fragments, beyond species or known reference genomes.
Transform untapped microbial data into clinically actionable biomarkers at unprecedented scale, accelerating drug development and personalized medicine.

Our Partners

Get In Touch

We’re eager to hear from you!